Vyvgart Hytrulo efgartigimod alfa 1,008 mg and hyaluronidase 11,200 units per 5.6 mL (180 mg/2,000 units per mL) single-dose vial Images

Generic Name: efgartigimod alfa/hyaluronidase

This medication has been identified as Vyvgart Hytrulo efgartigimod alfa 1,008 mg and hyaluronidase 11,200 units per 5.6 mL (180 mg/2,000 units per mL) single-dose vial. It is supplied by argenx US, Inc.

Vyvgart Hytrulo is used in the treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy; Myasthenia Gravis and belongs to the drug class immune globulins. Vyvgart Hytrulo efgartigimod alfa 1,008 mg and hyaluronidase 11,200 units per 5.6 mL (180 mg/2,000 units per mL) single-dose vial is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Vyvgart Hytrulo

Generic Name: efgartigimod alfa/hyaluronidase
Strength: efgartigimod alfa 1,008 mg and hyaluronidase 11,200 units per 5.6 mL (180 mg/2,000 units per mL) single-dose vial
Availability: Prescription only
Drug Class: Immune globulins
CSA Schedule: Not a controlled drug
Labeler / Supplier: argenx US, Inc.
Manufacturer: Halozyme Therapeutics, Inc.
National Drug Code (NDC): 73475-3102